Kluijtmans L A, Boers G H, Stevens E M, Renier W O, Kraus J P, Trijbels F J, van den Heuvel L P, Blom H J
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, The Netherlands.
J Clin Invest. 1996 Jul 15;98(2):285-9. doi: 10.1172/JCI118791.
We determined the molecular basis of cystathionine beta-synthase (CBS) deficiency in a partially pyridoxine-responsive homocystinuria patient. Direct sequencing of the entire CBS cDNA revealed the presence of a homozygous G1330A transition. This mutation causes an amino acid change from aspartic acid to asparagine (D444N) in the regulatory domain of the protein and abolishes a TaqI restriction site at DNA level. Despite the homozygous mutation, CBS activities in extracts of cultured fibroblasts of this patient were not in the homozygous but in the heterozygous range. Furthermore, we observed no stimulation of CBS activity by S-adenosylmethionine, contrary to a threefold stimulation in control fibroblast extract. The mutation was introduced in an E. coli expression system and CBS activities were measured after addition of different S-adenosylmethionine concentrations (0-200 microM). Again, we observed a defective stimulation of CBS activity by S-adenosylmethionine in the mutated construct, whereas the normal construct showed a threefold stimulation in activity. These data suggest that this D444N mutation interferes in S-adenosylmethionine regulation of CBS. Furthermore, it indicates the importance of S-adenosylmethionine regulation of the transsulfuration pathway in homocysteine homeostasis in humans.
我们确定了一名部分维生素B6反应性同型胱氨酸尿症患者中胱硫醚β-合酶(CBS)缺乏的分子基础。对整个CBS cDNA进行直接测序发现存在纯合的G1330A转换。该突变导致蛋白质调节域中的氨基酸从天冬氨酸变为天冬酰胺(D444N),并在DNA水平消除了一个TaqI限制性位点。尽管存在纯合突变,但该患者培养的成纤维细胞提取物中的CBS活性并非处于纯合范围,而是处于杂合范围内。此外,与对照成纤维细胞提取物中三倍的刺激作用相反,我们未观察到S-腺苷甲硫氨酸对CBS活性的刺激作用。将该突变引入大肠杆菌表达系统,并在添加不同浓度(0 - 200 microM)的S-腺苷甲硫氨酸后测量CBS活性。同样,我们在突变构建体中观察到S-腺苷甲硫氨酸对CBS活性的刺激作用存在缺陷,而正常构建体的活性有三倍的刺激作用。这些数据表明,这种D444N突变干扰了S-腺苷甲硫氨酸对CBS的调节。此外,这表明S-腺苷甲硫氨酸对转硫途径的调节在人类同型半胱氨酸稳态中的重要性。